About Biotex
Biotex is a Healthcare company based in United States founded in 1997. Novel technologies for medical diagnosis and therapy are developed. It operates on a Direct-to-Consumer (D2C) and Professional Services model. Biotex has raised $10.13 million across 33 funding rounds from investors including HHS and National Science Foundation. Biotex offers products and services including Visualase, Phasor Health, and Redpoint. Its focus areas include Medical Devices and Therapeutic Devices. Its legal entity is Biotex Inc.
Company details
Biotex is involved in the design, engineering, and manufacturing of medical devices aimed at addressing critical needs in patient care. The company operates within the healthcare sector, offering end-to-end solutions from research and strategy to commercialization. Services provided include product development, pre-clinical testing, clinical trials, regulatory support, and manufacturing. Innovative devices such as Visualase for seizure treatment and Phasor Health for surgical applications are developed to transform healthcare delivery.
- Headquarters United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website biotexmedical.com
- Social LinkedIn
- Legal Name Biotex Inc.
- Annual Revenue$197.48 K (USD)-10as on Dec 31, 2022
- Net Profit$32.67 (USD)-79as on Dec 31, 2022
- Total Equity Funding$10.13M (USD)
in 33 rounds
- Latest Funding Round$10.13M (USD), Series A
Apr 2024
- InvestorsHHS
& 1 more
Products & Services of Biotex
Biotex offers a comprehensive portfolio of products and services, including Visualase, Phasor Health, and Redpoint.
Non-invasive thermal ablation system for seizure treatment.
FDA-cleared disposable drill with ergonomic design.
Ultra-sensitive device for nanoscale biochemical analysis.
Funding Insights of Biotex
Biotex has successfully raised a total of $10.13M across 33 strategic funding rounds. The most recent funding activity was a Series A round of $10.13 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $10.13M
- Total Rounds 33
- Last Round Series A — $10.13M
- First Round $788,637
(Sep 2006)
- Investors Count 2
Latest 10 of 33 funding rounds of Biotex with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2024 | $10.13M | Series A | – | – | – |
| Oct 2020 | $995,000 | Unspecified | – | – | – |
| Jul 2020 | $2.15M | Grant | – | – | |
| Aug 2018 | $1.42M | Grant | – | – | |
| Sep 2017 | $1.49M | Grant | – | – | |
| Sep 2012 | $1.67M | Grant | – | – | |
| Sep 2012 | $367,110 | Grant | – | – | |
| Jun 2012 | $160,922 | Grant | – | – | |
| May 2012 | $160,922 | Grant | – | – | |
| May 2012 | $162,817 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in Biotex
Biotex has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Public health and human services are overseen by HHS. | 1953 | hhs.gov | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Biotex
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Biotex
1 people are tracked at Biotex (1 in team).
| Name | Role | Group |
|---|---|---|
Ashok Gowda | Executive Chairman | Team |
Complete people profiles for Biotex
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Biotex
3 dated milestones of Biotex across 27 years, from founding to its latest funding, stage changes and deals.
- Founded Biotex is founded.
- Funding First funding round of $789K.
- Funding Latest funding round, Series A, of $10.1M.
Web traffic of Biotex
The website of Biotex (biotexmedical.com) receives about 3.5K visits a month.
- Monthly visits3.5K
▲ 18.9% vs previous month
Websites whose visitors overlap most with Biotex. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biotexlife.com | 100% | 1.5K | #10,342,508 | View details |
Top companies in Diversified Medical Devices
3 companies that operate in the same segment as Biotex (Diversified Medical Devices) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medical equipment for treating over 30 chronic diseases is developed. | 1949 | Minneapolis, Minnesota, United States | USD 36.36 B | 95,000 | ||
Wide range of medical devices | 1979 | Marlborough, Massachusetts, United States | USD 20.07 B | 53,000 | ||
Healthcare solutions are provided by Johnson & Johnson globally. | 1886 | New Brunswick, New Jersey, United States | USD 94.18 B | 139,800 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Biotex
Biotex was founded in 1997 and raised its 1st funding round 9 years after it was founded.
Biotex is headquartered in United States.
Biotex is a funded company, having raised a total of $10.13M across 33 funding rounds to date. The company's 1st funding round was a Grant of $162.82K, raised on Sep 2006.
Annual revenue of Biotex is $197.48K as on Dec 31, 2022.
Biotex is involved in the design, engineering, and manufacturing of medical devices aimed at addressing critical needs in patient care. The company operates within the healthcare sector, offering end-to-end solutions from research and strategy to commercialization. Services provided include product development, pre-clinical testing, clinical trials, regulatory support, and manufacturing. Innovative devices such as Visualase for seizure treatment and Phasor Health for surgical applications are developed to transform healthcare delivery.
Biotex offers Visualase, Phasor Health, and Redpoint.
Biotex has 2 investors. Key investors include HHS, and National Science Foundation.
Biotex operates through Biotex Inc..